Genevant Sciences
PrivateLast Round
Corporate Funding
Jul 31, 2020
Est. Valuation
$87.5M
Total Funding Raised
$40M
Company Overview
Genevant Sciences is a biotechnology company that provides nucleic acid delivery technology, including lipid nanoparticle (LNP) platforms, for the development of RNA-based therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Pharma Supply Chain
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Genevant Sciences Comparables
Compare Genevant Sciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Acuitas Therapeutics | 92% | |
| NanoVation Therapeutics | 88% | |
| Lemonex Inc. | 77% | |
Genevant Sciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Jul 31, 2020 | ||||
| Seed | Apr 11, 2018 |
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 27, 2024
Monthly visitors increased 555% MoM, reaching 7.2K.
- Aug 13, 2023
Grew 18% QoQ from 40 to 47 employees.
Genevant Sciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Genevant Sciences's valuation, stock price, and market status.